Nortech Systems, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6565531042
USD
16.80
-0.78 (-4.44%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

641

Shareholding (Mar 2026)

FII

0.12%

Held by 3 FIIs

DII

99.88%

Held by 2 DIIs

Promoter

0.00%

Is Nortech Systems, Inc. overvalued or undervalued?

20-Sep-2025

As of March 31, 2025, Nortech Systems, Inc. is considered risky due to overvaluation indicated by negative valuation ratios and poor stock performance, with a year-to-date return of -8.36% compared to the S&P 500's 12.22%.

As of 31 March 2025, the valuation grade for Nortech Systems, Inc. has moved from fair to risky, indicating a significant deterioration in its financial health. The company appears to be overvalued, particularly given its negative valuation ratios, including a Price to Book Value of 0.75, an EV to EBITDA of -37.33, and an EV to Sales of 0.31. <BR><BR>In comparison to its peers, Nortech Systems' EV to EBITDA ratio of -37.33 is worse than LENSAR, Inc. at -12.34 and Singular Genomics Systems, Inc. at 0.55, both of which also carry a risky valuation. Additionally, the company's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -8.36% compared to the index's 12.22%, further reinforcing the notion of overvaluation.

View full answer

Is Nortech Systems, Inc. technically bullish or bearish?

20-Sep-2025

As of August 28, 2025, Nortech Systems, Inc. shows a mildly bearish trend overall, with mixed technical indicators and significant underperformance compared to the S&P 500, reflecting a bearish sentiment despite some short-term bullish signals.

As of 28 August 2025, the technical trend for Nortech Systems, Inc. has changed from sideways to mildly bearish. The weekly MACD and KST indicators are mildly bullish, but the monthly MACD and KST are bearish, indicating mixed signals across different time frames. The daily moving averages are mildly bearish, and the Bollinger Bands show a mildly bullish stance on the weekly but mildly bearish on the monthly. Overall, the Dow Theory supports a mildly bullish view on both weekly and monthly time frames. <BR><BR>In terms of performance, Nortech has underperformed the S&P 500 across multiple periods, with a year-to-date return of -8.36% compared to the S&P's 12.22%, and a one-year return of -20.29% versus 17.14% for the index. This suggests a bearish sentiment despite some bullish indicators in the shorter term.

View full answer

How big is Nortech Systems, Inc.?

22-Jun-2025

As of Jun 18, Nortech Systems, Inc. has a market capitalization of 23.91 million, with net sales of 120.81 million and a net profit of -3.38 million over the last four quarters. The company reported shareholder's funds of 34.01 million and total assets of 72.44 million as of Dec 24.

Market Cap: As of Jun 18, Nortech Systems, Inc. has a market capitalization of 23.91 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Nortech Systems, Inc. reported net sales of 120.81 million and a net profit of -3.38 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 34.01 million and total assets of 72.44 million.

View full answer

What does Nortech Systems, Inc. do?

22-Jun-2025

Nortech Systems, Inc. is a micro-cap electronic manufacturing services company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $27 million and a net profit of -$1 million. The company has a market cap of $23.91 million and key metrics include a debt equity ratio of 0.39 and a return on equity of -7.77%.

Overview: <BR>Nortech Systems, Inc. is an electronic manufacturing services (EMS) company operating in the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap firm.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 27 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 23.91 Million (Micro Cap)<BR><BR>Key Metrics: <BR>Debt Equity: 0.39 <BR>Return on Equity: -7.77% <BR>Price to Book: 0.73<BR><BR>Contact Details: <BR>Address: 7550 Meridian Cir N Ste 150, MAPLE GROVE MN: 55369-4932 <BR>Tel: 1 952 3452244 <BR>Fax: 1 952 4490442 <BR>Website: http://www.nortechsys.com

View full answer

Should I buy, sell or hold Nortech Systems, Inc.?

22-Jun-2025

Who are in the management team of Nortech Systems, Inc.?

22-Jun-2025

As of March 2022, the management team of Nortech Systems, Inc. includes David Kunin (Chairman), Jay Miller (President and CEO), Kathleen Iverson, Danny Sachs, Philip Smith (all Directors), and independent Directors Kenneth Larson and Richard Perkins. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Nortech Systems, Inc. includes the following individuals:<BR><BR>- David Kunin, Chairman of the Board<BR>- Mr. Jay Miller, President, Chief Executive Officer, and Director<BR>- Ms. Kathleen Iverson, Director<BR>- Dr. Danny Sachs, Director<BR>- Mr. Philip Smith, Director<BR>- Kenneth Larson, Independent Director<BR>- Mr. Richard Perkins, Independent Director<BR><BR>This team is responsible for guiding the company's strategic direction and operations.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor Management Efficiency with a low ROCE of 8.91%

  • The company has been able to generate a Return on Capital Employed (avg) of 8.91% signifying low profitability per unit of total capital (equity and debt)
2

Poor long term growth as Net Sales has grown by an annual rate of 2.60% over the last 5 years

 
3

With a growth in Net Sales of 12.72%, the company declared Very Positive results in Mar 26

4

With ROE of 0.04%, it has a expensive valuation with a 0.95 Price to Book Value

5

Increasing Participation by Institutional Investors

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 33 Million (Micro Cap)

stock-summary
P/E

33.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.20

stock-summary
Return on Equity

0.04%

stock-summary
Price to Book

0.95

Revenue and Profits:
Net Sales:
30 Million
(Quarterly Results - Mar 2026)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
66.67%
0%
66.67%
6 Months
125.53%
0%
125.53%
1 Year
100.69%
0%
100.69%
2 Years
28.15%
0%
28.15%
3 Years
82.21%
0%
82.21%
4 Years
42.25%
0%
42.25%
5 Years
127.98%
0%
127.98%

Nortech Systems, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
2.60%
EBIT Growth (5y)
21.08%
EBIT to Interest (avg)
1.88
Debt to EBITDA (avg)
0.74
Net Debt to Equity (avg)
0.39
Sales to Capital Employed (avg)
2.94
Tax Ratio
10.07%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
5.61%
ROCE (avg)
8.91%
ROE (avg)
7.90%

Valuation key factors

Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
0.95
EV to EBIT
32.16
EV to EBITDA
15.78
EV to Capital Employed
0.96
EV to Sales
0.34
PEG Ratio
0.33
Dividend Yield
NA
ROCE (Latest)
2.99%
ROE (Latest)
0.04%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 4 Schemes (1.85%)

Foreign Institutions

Held by 3 Foreign Institutions (0.12%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 12.64% vs -21.35% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 100.00% vs -262.50% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.30",
          "val2": "26.90",
          "chgp": "12.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.30",
          "val2": "-1.00",
          "chgp": "130.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.20",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.00",
          "val2": "-1.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.60%",
          "val2": "-50.10%",
          "chgp": "5.17%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -7.57% vs -8.04% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 76.92% vs -118.84% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "118.40",
          "val2": "128.10",
          "chgp": "-7.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.50",
          "val2": "2.10",
          "chgp": "19.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "0.70",
          "chgp": "42.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "-0.60",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.30",
          "val2": "-1.30",
          "chgp": "76.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.50%",
          "val2": "2.90%",
          "chgp": "0.76%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
30.30
26.90
12.64%
Operating Profit (PBDIT) excl Other Income
0.30
-1.00
130.00%
Interest
0.30
0.20
50.00%
Exceptional Items
0.00
-0.30
100.00%
Consolidate Net Profit
-0.00
-1.30
100.00%
Operating Profit Margin (Excl OI)
1.60%
-50.10%
5.17%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 12.64% vs -21.35% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 100.00% vs -262.50% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
118.40
128.10
-7.57%
Operating Profit (PBDIT) excl Other Income
2.50
2.10
19.05%
Interest
1.00
0.70
42.86%
Exceptional Items
-0.30
-0.60
50.00%
Consolidate Net Profit
-0.30
-1.30
76.92%
Operating Profit Margin (Excl OI)
10.50%
2.90%
0.76%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is -7.57% vs -8.04% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 76.92% vs -118.84% in Dec 2024

stock-summaryCompany CV
About Nortech Systems, Inc. stock-summary
stock-summary
Nortech Systems, Inc.
Pharmaceuticals & Biotechnology
Nortech Systems Incorporated is an electronic manufacturing services (EMS) company. The Company offers a range of value-added engineering, technical and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management and post-market services. The Company's segment is Contract Manufacturing. The Company's manufacturing and engineering services include medical devices, printed circuit board assemblies, wire and cable assemblies, and electromechanical assemblies. The Company's manufacturing facilities are located at Bemidji, Blue Earth, Merrifield, Eden Prairie, Milaca and Mankato in Minnesota; Augusta in Wisconsin; Monterrey in Mexico, and Suzhou in China. The Company serves approximately three markets within the EMS industry, such as Aerospace and Defense, Medical/Life Sciences and the Industrial market, which includes industrial equipment, transportation, vision, agriculture, oil and gas.
Company Coordinates stock-summary
Company Details
7550 Meridian Cir N Ste 150 , MAPLE GROVE MN : 55369-4932
stock-summary
Tel: 1 952 3452244
stock-summary
Registrar Details